CNS & Neurological Disorders - Drug Targets
Title:Dendrites, 3rd Edition
Volume: 16 Issue: 6
Author(s): M. Foster Olive*
Affiliation:
- Department of Psychology, Arizona State University, Tempe, Arizona 85287,United States
Export Options
About this article
Cite this article as:
Olive Foster M. *, Dendrites, 3rd Edition, CNS & Neurological Disorders - Drug Targets 2017; 16 (6) . https://dx.doi.org/10.2174/1871527316999170505104950
DOI https://dx.doi.org/10.2174/1871527316999170505104950 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
Call for Papers in Thematic Issues
Diagnosis and treatment of central nervous system infectious diseases
Infectious diseases of the central nervous system (CNS) can be divided into bacterial, tuberculous, viral, fungal, parasitic infections, etc. Early etiological treatment is often the most crucial means to reduce the mortality rate of patients with central nervous system infections, reduce complications and sequelae, and improve prognosis. The initial clinical ...read more
Techniques of Drug Repurposing: Delivering a new life to Herbs & Drugs
Of late, with the adaptation of innovative approaches and integration of advancements made towards medical sciences as well as the availability of a wide range of tools; several therapeutic challenges are being translated into viable clinical solutions, with a high degree of efficacy, safety, and selectivity. With a better understanding ...read more
Trends and perspectives in the rational management of CNS disorders
Central nervous system (CNS) diseases enforce a significant global health burden, driving ongoing efforts to improve our understanding and effectiveness of therapy. This issue investigates current advances in the discipline, focusing on the understanding as well as therapeutic handling of various CNS diseases. The issue covers a variety of diseases, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
What Fans the Fire: Insights into Mechanisms of Leptin in Metabolic Syndrome- Associated Heart Diseases
Current Pharmaceutical Design Large Scale Refolding and Purification of the Catalytic Domain of Human BACE-2 Produced in E. coli
Protein & Peptide Letters Novel Targets for Cardiac Antiarrhythmic Drug Development
Current Pharmaceutical Design Impact of MRI-based Segmentation Artifacts on Amyloid- and FDG-PET Quantitation
Current Alzheimer Research Studies on the Pathophysiology and Genetic Basis of Migraine
Current Genomics Association Study of 10 Candidate Genes with Sporadic Alzheimers Disease in a Spanish Population
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents FKBP Ligands as Novel Therapeutics for Neurological Disorders
Mini-Reviews in Medicinal Chemistry An Insight on the Association of Psychological Studies, Cognitive Sciences and Meditation in Treating Depression
Current Psychopharmacology Kratom and Future Treatment for the Opioid Addiction and Chronic Pain: Periculo Beneficium?
Current Drug Targets Conference Report: 10th International Summer School of Neurology: Celebrating a Decade of Success: 5th July, 2015 – 9th July, 2015 | Eforie Nord, Romania
CNS & Neurological Disorders - Drug Targets The Interleukin-1 System: An Attractive and Viable Therapeutic Target in Neurodegenerative Disease
Current Drug Targets - CNS & Neurological Disorders “Legal Highs” – New Players in the Old Drama
Current Drug Abuse Reviews Influence of Aging on the Dopaminergic Neurons in the Substantia Nigra Pars Compacta of Rats
Current Aging Science Pharmacological and Toxicological Profile of Harmane-β-Carboline Alkaloid: Friend or Foe
Current Drug Metabolism Neuroprotective Methodologies in the Treatment of Multiple Sclerosis Current Status of Clinical and Pre-clinical Findings
Current Drug Discovery Technologies Modulators of Voltage-Dependent Calcium Channels for the Treatment of Nervous System Diseases
Recent Patents on CNS Drug Discovery (Discontinued) Differentiation of Non-Pharmacological from Pharmacological Dopamine Release in the Living Human Brain
Current Medical Imaging Paullones as Inhibitors of Protein Kinases
Current Topics in Medicinal Chemistry Synthesis of Enantiopure Drugs and Drug Intermediates by Immobilized Lipase-Catalysis
Current Bioactive Compounds The Pharmacology of Human Appetite Expression
Current Drug Targets